Posted in | News

Bridgestone Establishes New R&D Facility to Evaluate Raw Materials in China

Bridgestone Corporation has announced that it would construct a new technical center in China. That followed a period of negotiations with Chinese authorities concerning the creation of an R&D site in the country. The new center will drive speedy R&D to ensure the supply of excellent quality raw materials to Bridgestone's production and sales companies in China.

The center will be built next to Bridgestone's Wuxi Plant, with operations expected to begin in July 2006. It will be capitalized with US$7.25 million (approximately ¥0.8 billion), while a total of US$14 million (approximately ¥1.5 billion) has been earmarked for investment in the project. It will be Bridgestone's fourth technical center worldwide following on from ones in Tokyo (Japan), Akron (USA) and Rome (Italy). At the new technical center in China, Bridgestone will evaluate the raw materials being supplied to the group's tire plants in China, with the aim of quickly boosting the applicability and quality of China's raw materials used in tires.

At present, Bridgestone Group's tire production bases in China include two tire plants for passenger cars (Tianjin and Wuxi) and one for truck and bus radials (Shenyang). Steady progress is also being made on the construction of a plant for truck and bus radials in Huizhou. Going forward, Bridgestone aims to strengthen its local research and development capabilities in line with rapid advancements in motorization in China. With the objective of continuously expanding business in the region, Bridgestone will create a consistent system from development to production and sales to enable quick response to diverse needs in the Chinese market.

http://www.bridgestone.co.jp

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.